Oriana Lo Re

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

Simone Jueliger, John F. Lyons, Sara Cannito et al. · Epigenetics · 2016 · 80 citations · Full text

Chemoprevention Strategy, Cancer Biology, Anti-cancer Agent +18

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation

Jana Pindjáková, Claudio Sartini, Oriana Lo Re et al. · Frontiers in Microbiology · 2017 · 79 citations · Full text

Dysbiosis, Host-microbe Interactions, Adaptive Immune Response +19

Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma

Oriana Lo Re, Caterina Fusilli, Francesca Rappa et al. · Hepatology · 2017 · 76 citations · Full text

Macrohistone H2a1, Human Hcc Sections, Pathology +19

Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin

Marco Raffaele, Kristína Kovačovicová, Jan Fröhlich et al. · Cell Communication and Signaling · 2021 · 57 citations · Full text

Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells

Oriana Lo Re, Concetta Panebianco, Stefania Porto et al. · Journal of Cellular Physiology · 2017 · 56 citations